These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7815876)

  • 1. Factor V Leiden mutation and venous thrombosis.
    Hatake K; Miura Y
    Lancet; 1995 Jan; 345(8942):133. PubMed ID: 7815876
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V Leiden mutation and venous thrombosis.
    Davies KA; Ireland H; Athanassiou P; Loizou S; Lane D; Walport MJ
    Lancet; 1995 Jan; 345(8942):132-3. PubMed ID: 7815875
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral contraception and factor V Leiden mutation in relation to localization of deep vein thrombosis.
    Andersen BS; Olsen J
    Thromb Res; 1998 May; 90(4):191-4. PubMed ID: 9692618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor V leiden and venous thromboembolism in a woman taking second generation oral contraceptives: a case report].
    Undas A; Sanak M; Jankowski M; Undas R; Musiał J; Szczeklik A
    Ginekol Pol; 1999 Feb; 70(2):93-7. PubMed ID: 10349814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.
    Vandenbroucke JP; Koster T; Briët E; Reitsma PH; Bertina RM; Rosendaal FR
    Lancet; 1994 Nov; 344(8935):1453-7. PubMed ID: 7968118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].
    Vandenbroucke JP; Briët E; Helmerhorst F; van der Meer FJ
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1067-71. PubMed ID: 7783798
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breakthrough in thrombosis research--can the use of contraceptive pills be safer than it used to be?].
    Lähteenmäki P
    Duodecim; 1995; 111(22):2097-8. PubMed ID: 9841168
    [No Abstract]   [Full Text] [Related]  

  • 9. Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis?
    Comp PC
    Contraception; 2006 Jan; 73(1):4-5. PubMed ID: 16371288
    [No Abstract]   [Full Text] [Related]  

  • 10. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End of the line for "third-generation-pill" controversy?
    Vandenbroucke JP; Rosendaal FR
    Lancet; 1997 Apr; 349(9059):1113-4. PubMed ID: 9113005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral contraceptives increase the chance of venous thrombosis in factor V Leiden mutation].
    Huikeshoven FJ; Lotgering FK
    Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1561-2. PubMed ID: 7675138
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraceptive users and screening of factor V Leiden.
    Aznar J; Gilabert J
    Thromb Haemost; 1999 May; 81(5):845-6. PubMed ID: 10365763
    [No Abstract]   [Full Text] [Related]  

  • 14. [APC resistance--most frequent familial thrombophilia].
    Herren S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):499-501. PubMed ID: 10517118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives.
    Bridey F; Wolff M; Laissy JP; Morin V; Lefebvre M; de Prost D
    Thromb Haemost; 1995 Nov; 74(5):1382. PubMed ID: 8607129
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor V Leiden and third-generation oral contraceptives.
    Westhoff C
    Lancet; 1996 Feb; 347(8998):396-7. PubMed ID: 8598719
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DVT following oral contraceptive therapy in association with homozygous factor V Leiden.
    Aslam S; Standen GR; Morse C; Scott GL
    Clin Lab Haematol; 1995 Mar; 17(1):99-100. PubMed ID: 7621640
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor V Leiden and contraception.
    Ament L
    J Midwifery Womens Health; 2004; 49(1):51-2. PubMed ID: 14710141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
    Nafa K; Bessler M; Mason P; Vulliamy T; Hillmen P; Castro-Malaspina H; Luzzatto L
    Haematologica; 1996; 81(6):540-2. PubMed ID: 9009443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.